echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Eur J Nucl Med Mol Imaging: Using PERCIST to predict tumor response and prognosis of patients with esophageal squamous cell carcinoma to neoadjuvant chemotherapy

    Eur J Nucl Med Mol Imaging: Using PERCIST to predict tumor response and prognosis of patients with esophageal squamous cell carcinoma to neoadjuvant chemotherapy

    • Last Update: 2021-05-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Esophageal cancer is the eighth most common cancer in the world.


    This study aims to explore the value of positron emission tomography response standard 1.


    The researchers analyzed 177 ESCC patients and assessed the correlation between PERCIST and its pathological response.


    177 ESCC patients

    The pathological response of primary tumors was significantly correlated with PERCIST (p<0.


    The best cut-off value of primary tumor SULpeak response to pathological response is -50.


    PFS of different subgroups according to survival tree analysis

    PFS of different subgroups according to survival tree analysis

    In addition, Whole-PERCIST is also significantly related to PFS and OS .


    Whole-PERCIST is also significantly related to PFS and OS Whole-PERCIST is also significantly related to PFS and OS

    OS of different subgroups based on survival tree analysis

    OS of different subgroups based on survival tree analysis

    All in all, PERCIST1.


    PERCIST1.


    Original source:

    Kaida, H.


    org/10.
    1007/s00259-021-05365-5">Predicting tumor response and prognosis to neoadjuvant chemotherapy in esophageal squamous cell carcinoma patients using PERCIST: a multicenter study in Japan

    in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.